chr4-25662722-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_006424.3(SLC34A2):c.130C>T(p.Pro44Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000613 in 1,614,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P44R) has been classified as Uncertain significance.
Frequency
Consequence
NM_006424.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC34A2 | NM_006424.3 | c.130C>T | p.Pro44Ser | missense_variant | 3/13 | ENST00000382051.8 | |
SLC34A2 | NM_001177998.2 | c.127C>T | p.Pro43Ser | missense_variant | 3/13 | ||
SLC34A2 | NM_001177999.2 | c.127C>T | p.Pro43Ser | missense_variant | 3/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC34A2 | ENST00000382051.8 | c.130C>T | p.Pro44Ser | missense_variant | 3/13 | 1 | NM_006424.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000316 AC: 48AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251470Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135906
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461892Hom.: 0 Cov.: 33 AF XY: 0.0000220 AC XY: 16AN XY: 727248
GnomAD4 genome AF: 0.000315 AC: 48AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74446
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.130C>T (p.P44S) alteration is located in exon 3 (coding exon 2) of the SLC34A2 gene. This alteration results from a C to T substitution at nucleotide position 130, causing the proline (P) at amino acid position 44 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at